Background: Cathepsin G, a serine protease that is activated by ultraviolet (UV) radiation, increases matrix metalloproteinase-1 (MMP-1) expression in fibroblasts through fibronectin (Fn) fragmentation and promotes the conversion of proMMP-1 to active MMP-1. Objectives: This study investigated whether [2-[3-[[(1-benzoyl-4-piperidinyl)methylamino]carbonyl]-2-naphthalenyl]-1-(1-naphthalenyl)-2-oxoethyl]-phosphonic acid (KPA), a cathepsin G inhibitor, plays any role in extracellular matrix (ECM) damage in an in vitro 3D dermal equivalent (DE) and an in vivo ultraviolet B (UVB)-irradiated hairless mice. Methods: We examined the potential ECM-protective effects of a cathepsin G inhibitor in an in vitro 3D DE model and an in vivo UVB-irradiated hairless mouse skin model. Results: Among five known serine protease inhibitors, KPA showed the strongest potency and selectivity against cathepsin G. KPA inhibited the cathepsin G-mediated MMP-1 increase and alleviated the downregulation of mRNAs encoding collagen and tissue inhibitor of matrix metalloproteinase-1 in an in vitro 3D DE model. Most importantly, topical application of KPA (0.025%) to the dorsal skin of hairless mice enhanced collagen expression and attenuated UVB-induced Fn fragmentation and upregulation of MMP-2 and MMP-9 activities. Conclusions: Cathepsin G inhibitors may be useful for the prevention of UVB-induced photoaging through amelioration of ECM damage and MMP upregulation.

Keywords:
Cathepsin G, Fibronectin, Matrix metalloproteinase, Skin, Photoaging
1.
Chung JH: Photoaging in Asians. Photodermatol Photoimmunol Photomed 2003;19:109–121.
2.
Jenkins G: Molecular mechanisms of skin aging. Mech Ageing Dev 2002;123:801–810.
3.
Rittie L, Fisher GJ: UV-light-induced signal cascades and skin aging. Ageing Res Rev 2002;1:705–720.
4.
Hughes MC, Bredoux C, Salas F, Lombard D, Strutton GM, Fourtanier A, Green AC: Comparison of histological measures of skin photoaging. Dermatology 2011;223:140–151.
5.
Fagot D, Asselineau D, Bernerd F: Direct role of human dermal fibroblasts and indirect participation of epidermal keratinocytes in MMP-1 production after UV-B irradiation. Arch Dermatol Res 2002;293:576–583.
6.
Carnemollar B, Cutolo M, Castellani P, Balza E, Raffanti S, Zardi L: Characterization of synovial fluid fibronectin from patients with rheumatic inflammatory diseases and healthy subjects. Arthritis Rheum 1984;27:913–921.
7.
Xie DL, Meyers R, Homandberg GA: Fibronectin fragments in osteoarthritic synovial fluid. J Rheumatol 1992;19:1448–1452.
8.
Homandberg GA, Wen C, Hui F: Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage 1998;6:231–244.
9.
Stanton H, Ung L, Fosang AJ: The 45 kDa collagen-binding fragment of fibronectin induces MMP-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. Biochem J 2002;364:181–190.
10.
Vassiliadis E, Veidal SS, Barascuk N, Mullick JB, Clausen RE, Larsen L, Simonsen H, Larsen DV, Bay-Jensen AC, Segovia-Silvestre T, Leeming DJ, Karsdal MA: Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosis. BMC Dermatol 2011;11:6.
11.
Varani J, Schuger L, Dame MK, Leonard C, Fligiel SE, Kang S, Fisher GJ, Voorhees JJ: Reduced fibroblast interaction with intact collagen as a mechanism for depressed collagen synthesis in photodamaged skin. J Invest Dermatol 2004;122:1471–1479.
12.
Hynes RO: Fibronectins. New York, Springer, 1990.
13.
Labat-Robert J: Fibronectin in malignancy. Semin Cancer Biol 2002;12:187–195.
14.
Vartio T: Characterization of the binding domains in the fragments cleaved by cathepsin G from human plasma fibronectin. Eur J Biochem 1982;123:223–233.
15.
Cawston T, Rowan D: Mechanisms of cartilage breakdown and repair. Arthritis Research Reports on Rheum 1998;15.
16.
Watorek W, Farley D, Salvesen G, Travis J: Neutrophil elastase and cathepsin G: structure, function, and biological control. Adv Exp Med Biol 1988;240:23–31.
17.
Cavarra E, Fimiani M, Lunqarella G, Andreassi L, de Santi M, Mazzatenta C, Ciccoli L: UVA light stimulates the production of cathepsin G and elastase-like enzymes by dermal fibroblasts: a possible contribution to the remodeling of elastotic areas in sun-damaged skin. Biol Chem 2002;383:199–206.
18.
Zheng Y, Lai W, Wan M, Maibach HI: Expression of cathepsins in human skin photoaging. Skin Pharm Physiol 2011;124:10–21.
19.
Son ED, Kim H, Choi H, Lee SH, Lee JY, Kim S, Closs B, Lee S, Chung JH, Hwang JS: Cathepsin G increases MMP expression in normal human fibroblasts through fibronectin fragmentation, and induces the conversion of proMMP-1 to active MMP-1. J Dermatol Sci 2009;53:150–152.
20.
Greco M, Hawkins M, Powell E, Almond H, Corcoran T, de Garavilla L, Kauffman JA, Recacha R, Chattopadhyay D, Andrade-Gordon P, Maryanoff BE: Nonpeptide inhibitors of cathepsin G: optimization of a novel beta-ketophosphonic acid lead by structure-based drug design. J Am Chem Soc 2002;124:3810–3811.
21.
Harper JW, Hemmi K, Powers JC: Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor. Biochemistry 1985;24:1831–1841.
22.
Powers JC, Tanaka T, Harper JW, Minematsu Y, Barker L, Lincoln D, Crumley KV, Fraki JE, Schechter NM, Lazarus GG: Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors. Biochemistry 1985;24:2048–2058.
23.
Seemüller U, Eulitz M, Fritz H, Strobl A: Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis. Hoppe Seylers Z Physiol Chem 1980;361:1841–1846.
24.
Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ: Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 1995;131:775–789.
25.
Nakagawa K, Tsuji T, Kadoya A, Hamada T: Elastase-like enzyme activity in cultured human fibroblast. Skin Res 1987;29:793–797.
26.
Gangatirkar P, Paquet-Fifield S, Li A, Rossi R, Kaur P: Establishment of 3D organotypic cultures using human neonatal epidermal cells. Nat Protoc 2007;2:178–186.
27.
Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
28.
Bonnefoy A, Legrand C: Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb Res 2000;98:323–332.
29.
Labat-Robert J, Fourtainier A, Boyer-Lafarque B, Robert L: Age dependent increase of elastase type protease activity in mouse skin. Effect of UV-irradiation. J Photochem Photobiol B 2000;57:113–118.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.